Baird Financial Group, Inc. Exact Sciences Corp Transaction History
Baird Financial Group, Inc.
- $54.4 Billion
- Q2 2025
A detailed history of Baird Financial Group, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 280,348 shares of EXAS stock, worth $18.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
280,348
Previous 310,566
9.73%
Holding current value
$18.8 Million
Previous $13.4 Million
10.81%
% of portfolio
0.03%
Previous 0.03%
Shares
33 transactions
Others Institutions Holding EXAS
# of Institutions
656Shares Held
158MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.22 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$811 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$807 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$362 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...